228 related articles for article (PubMed ID: 32997837)
1. Increased level of cathelicidin (LL-37) in vitiligo: Possible pathway independent from vitamin D receptor gene polymorphism.
Atazadeh F; Fazeli Z; Vahidnezhad H; Namazi N; Younespour S; Youssefian L; Abdollahimajd F; Uitto J
Exp Dermatol; 2020 Dec; 29(12):1176-1185. PubMed ID: 32997837
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the correlation between serum levels of vitamin D and vitamin D receptor gene polymorphisms in an Egyptian population.
Sobeih S; Mashaly HM; Gawdat H; Amr K; Hamid MF; Shaalan E
Int J Dermatol; 2016 Dec; 55(12):1329-1335. PubMed ID: 27420410
[TBL] [Abstract][Full Text] [Related]
3. The association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with generalized vitiligo.
Li K; Shi Q; Yang L; Li X; Liu L; Wang L; Li Q; Wang G; Li CY; Gao TW
Br J Dermatol; 2012 Oct; 167(4):815-21. PubMed ID: 22762534
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphisms in the vitamin D receptor gene and serum 25-hydroxyvitamin D levels in children with autism spectrum disorder.
Coşkun S; Şimşek Ş; Camkurt MA; Çim A; Çelik SB
Gene; 2016 Aug; 588(2):109-14. PubMed ID: 27155524
[TBL] [Abstract][Full Text] [Related]
5. Analysis of vitamin D receptor gene polymorphisms in vitiligo.
Aydıngöz IE; Bingül I; Doğru-Abbasoğlu S; Vural P; Uysal M
Dermatology; 2012; 224(4):361-8. PubMed ID: 22738935
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between Urothelial Type Bladder Cancer, Plasma 25-Hydroxyvitamin D Levels, and Vitamin D Receptor ApaI BsmI FokI, and TaqI Polymorphisms.
Baykan O; Akgul M; Uren N; Yaman A; Tinay I; Ergul E; Sazci A; Turkeri L; Haklar G
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969078
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Receptor Gene Expression and Function in a South African Population: Ethnicity, Vitamin D and FokI.
O Neill V; Asani FF; Jeffery TJ; Saccone DS; Bornman L
PLoS One; 2013; 8(6):e67663. PubMed ID: 23805323
[TBL] [Abstract][Full Text] [Related]
8. Association between vitamin D receptor polymorphisms and vitiligo susceptibility: An updated meta-analysis.
Lee YH; Song GG
J Cosmet Dermatol; 2023 Mar; 22(3):969-979. PubMed ID: 36254395
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of vitamin D receptor gene polymorphisms (ApaI and TaqI) as risk factors of vitiligo and predictors of response to narrowband UVB phototherapy.
Youssef YE; Eldegla HEA; Elmekkawy RSM; Gaballah MA
Arch Dermatol Res; 2023 Apr; 315(3):379-386. PubMed ID: 35318513
[TBL] [Abstract][Full Text] [Related]
10. Association of genetic variants of the vitamin D receptor gene with vitiligo in a tertiary care center in a Saudi population: a case-control study.
Saif GB; Khan IA
Ann Saudi Med; 2022; 42(2):96-106. PubMed ID: 35380061
[TBL] [Abstract][Full Text] [Related]
11. Impact of vitamin D receptor gene polymorphisms on vitiligo susceptibility and clinical features in a Southeastern European Caucasian population.
Katsarou MS; Sidiropoulou P; Ieronymaki D; Mastraftsi S; Sifaki M; Xenos K; Nosyrev A; Kovatsi L; Spandidos DA; Lagiou M; Dagklis C; Gregoriou S; Tagka A; Rigopoulos D; Drakoulis N; Nicolaidou E
Int J Mol Med; 2020 Nov; 46(5):1899-1907. PubMed ID: 33000207
[TBL] [Abstract][Full Text] [Related]
12. Association of Fok1 VDR polymorphism with Vitamin D and its associated molecules in pulmonary tuberculosis patients and their household contacts.
Panda S; Tiwari A; Luthra K; Sharma SK; Singh A
Sci Rep; 2019 Oct; 9(1):15251. PubMed ID: 31649297
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor gene polymorphism, serum 25-hydroxyvitamin D levels, and risk of vitiligo: A meta-analysis.
Zhang JZ; Wang M; Ding Y; Gao F; Feng YY; Yakeya B; Wang P; Wu XJ; Hu FX; Xian J; Kang XJ
Medicine (Baltimore); 2018 Jul; 97(29):e11506. PubMed ID: 30024533
[TBL] [Abstract][Full Text] [Related]
14. Plasma 1,25 dihydroxy vitamin D3 level and expression of vitamin d receptor and cathelicidin in pulmonary tuberculosis.
Selvaraj P; Prabhu Anand S; Harishankar M; Alagarasu K
J Clin Immunol; 2009 Jul; 29(4):470-8. PubMed ID: 19219539
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D status, vitamin D receptor gene polymorphism, and haplotype in patients with cutaneous leishmaniasis: Correlation with susceptibility and parasite load index.
Salem DA; Alghamdi MA; Al-Ghamdi HS; Alghamdi BA; Elsamanoudi AZE; Hasan A
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011393. PubMed ID: 37319132
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D status and vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Egyptian children.
Abd-Allah SH; Pasha HF; Hagrass HA; Alghobashy AA
Gene; 2014 Feb; 536(2):430-4. PubMed ID: 24370753
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D Receptor Gene Polymorphism and Vitamin D Status in Population of Patients with Cardiovascular Disease-A Preliminary Study.
Abouzid M; Kruszyna M; Burchardt P; Kruszyna Ł; Główka FK; Karaźniewicz-Łada M
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578994
[TBL] [Abstract][Full Text] [Related]
18. Association of the BsmI, ApaI, TaqI, Tru9I and FokI Polymorphisms of the Vitamin D Receptor Gene with Nephrolithiasis in the Turkish Population.
Cakir OO; Yilmaz A; Demir E; Incekara K; Kose MO; Ersoy N
Urol J; 2016 Mar; 13(1):2509-18. PubMed ID: 26945655
[TBL] [Abstract][Full Text] [Related]
19. Role of serum MMP-9 levels and vitamin D receptor polymorphisms in the susceptibility to coronary artery disease: An association study in Iranian population.
Moradi N; Fadaei R; Ahmadi R; Mohammad MH; Shahmohamadnejad S; Tavakoli-Yaraki M; Aghajani H; Fallah S
Gene; 2017 Sep; 628():295-300. PubMed ID: 28739397
[TBL] [Abstract][Full Text] [Related]
20. Association of serum levels and receptor genes BsmI, TaqI and FokI polymorphisms of vitamin D with the severity of multiple sclerosis.
Moosavi E; Rafiei A; Yazdani Y; Eslami M; Saeedi M
J Clin Neurosci; 2021 Feb; 84():75-81. PubMed ID: 33485603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
